| Description | C18 L-erythro Ceramide (d18:1/18:0) significantly reduced extracellular Aβ levels and can be used to study Alzheimer's disease. |
| molecular weight | 565.95 |
| Molecular formula | C36H71NO3 |
| CAS | 252039-52-4 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
| Solubility | DMSO: 2 mg/mL (3.53 mM), Sonication is recommended. |
| References | 1. Kim MJ,et al. Acid ceramidase inhibition ameliorates α-synuclein accumulation upon loss of GBA1 function. Hum Mol Genet. 2018 Jun 1;27(11):1972-1988. 2. Abeytunga DT,et al. Presence of unsaturated sphingomyelins and changes in their composition during the life cycle of the moth Manduca sexta. J Lipid Res. 2004 Jul;45(7):1221-31. |
C18 L-erythro Ceramide (d18:1/18:0)
CAS No.: 252039-52-4
C18 L-erythro Ceramide (d18:1/18:0) significantly reduced extracellular Aβ levels and can be used to study Alzheimer's
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.